HIV innate immunity · HIV and dendritic cells: the immunologycal and virological roles of SamHD1
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2012-05-14 → 2014-05-13
- Финансиране от ЕС
- 193 595 €
- Участници
- 1
- Схема
- MC-IEF
Линиите свързват координатора с партньорите.
Накратко на български
Дендритните клетки използват протеина SAMHD1, за да спрат репликацията на HIV-1, което превръща тези клетки в „троянски коне“ за вируса. Разбирането на този механизъм помага да се разбере защо HIV-1 е по-опасен от подобни вируси, които могат да разграждат SAMHD1.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
HIV and dendritic cells: the immunologycal and virological roles of SamHD1
Dendritic cells (DC) are antigen-presenting cells linking innate and adaptive immune responses against many pathogens. Their main function is to capture the pathogen and present it to other immune cells in order to trigger an initial immune response (mainly interpheron-based) that will ultimately lead to a more specific antibody-based response. The human immunodeficiency virus (HIV-1) is a retroviruses that causes acquired immunodeficiency syndrome (AIDS) a condition of progressive failure of the immune system until subsequent oportunistic infection will end with the patient´s life. The actual anti-retroviral treatment against HIV-1 has increased significantly the life expectancy of the infected patients, however, a complete erradication of the virus is still a matter of study. Recent findings point out that DC are poorly sensitive to HIV-1 suggesting that the virus may remain hidden and undetected by our innate immune system. Two years ago, two different groups discovered a factor present in DC that was essential for the infection of these cells with HIV-1, named SAMHD1. It functions as a deoxynucleotide triphosphate hydrolase and also has enzymatic activity to degrade the excess of DNA inside the cells. The presence of SAMHD1 stops the replication life cycle of HIV-1 within the cell. Instead, HIV-1 use DC as trojan horses to travel throughout the body without being detected and finally reach their target, the lymphocyte CD4 T cells. HIV-1 shares many similarities with HIV-2 and the simian immunodeficiency virus SIV, two different viruses with a less pathogenic outcome. However, SIV and HIV-2, both contain a protein in its genome, Vpx, that degrades the factor SAMHD1, whereas HIV-1 does not. A possible relationship between the presence of Vpx and the pathogeneicity of the infection has been a hypothesis of this study. Besides, HIV-1 is known to be transmitted between cells, through cellular contacts or virologycal synapses. This is a more rapid and efficient mechanism for HIV-1 to spread. Previous studies that showed the role of SAMHD1 in the retsriction to HIV-1 infection in DC were performed in vitro using cell-fre viral preparations. We have developed a system of cell-to-cell HIV-1 transmission and evaluated the effect of SAMHD1 during this highly efficient mode of spread. Our results probed that SAMHD1 is active during cell-to-cell transmission and no IFN-immune response is triggered in the presence of SAMHD1. Removing SAMHD1 by adding the Vpx protein or using gene-silecning tools showed an increase in the infection and detection of HIV by DC. Comparative studies between HIV-1 and HIV-2 on infection and immune detection by DC were performed in collaboration with the PhD student Lise Chauveau. There is still some ongoing work on this project. Understanding how HIV-1 evades the innate immune response is clue to completely erradicate the virus. HIV-1 remains hidden in the cells of the immune system, which in turn become reservoirs for the virus. New therapetic strategis are needed to target these reservoirs of infected cells. This will utlimately have an impact on the cure for this pandemic disease.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Dendritic cells (DC) are the front-line of virus detection and trigger the response of the innate and adaptive immune system. DCs ""patrol"" in the body and seek pathogens such as viruses. When they catch viruses, they initiate immune responses primarily in lymph nodes and lymphoid tissue. DCs acquire a mature phenotype while they migrate towards the lymphoid tissues in order to process and present the antigens derived from viruses. They also produce various cytokines and chemokines, substances with pro-inflammatory properties. Antigen presentation by DCs can activate the immune system by inducing specific CD4 and CD8 T lymphocytes responses, responsible for destroying the virus. DCs are relatively resistant to infection by HIV. A cell antiviral factor named SAMHD1, was recently identified as protecting DCs and macrophages from productive infection by HIV-1. We want to characterize the SAMHD1 mechanism of action, how and why it protects DCs from HIV infection. HIV infection is mainly achieved by the formation of cellular contact between infected cells and target cells, thus we aim to examine the role of SAMHD1 during these contacts. We will also study the role of SAMHD1 in the induction of the immune response against HIV. This project is in collaboration with the team of Monsef Benkirane, which has recently identified the protein SamHD1, and the team of Yves Levy. We expect to unmask how HIV has evolved to escape from the immune response; a relevant issue to better understand why nowadays treatments have failed to completely eradicate the virus.""
Оригинален текст от CORDIS (на английски).
Участници
- INSTITUT PASTEUR · ParisКоординаторФранция
Връзки
Данни: CORDIS, © Европейски съюз
